This is a rare genetic condition that causes amyloid, a type of protein, to build up in the walls of small blood vessels in the brain. This buildup can make the vessels weak and prone to bleeding, leading to sudden strokes or brain hemorrhages. It's inherited, meaning you get it from your parents.
Every report comes from a Lived member, sent anonymously.
Have you tried High Blood Pressure Medications for Hereditary Cerebral Amyloid Angiopathy?
Hereditary cerebral amyloid angiopathy (CAA) is a rare inherited condition in which an abnormal protein, called amyloid, builds up in the walls of small blood vessels in the brain. The amyloid replaces the muscle and elastic tissue that normally keep these vessels flexible, so they become fragile and can break. The main results are bleeding in the brain (a type of stroke) and a gradual decline in memory and thinking, usually beginning in mid-adulthood. There are several types, named after the places where families with them were first described, and they behave differently. In the Dutch type, the most common, a brain bleed is often the first sign. The Icelandic type tends to cause strokes much earlier, often in a person's twenties or thirties. Other types, such as the Arctic and Iowa types, rarely cause strokes and instead show up mainly as memory loss and dementia. Hereditary CAA is different from the far more common sporadic CAA, which develops in older adults without an inherited cause.
Hereditary CAA is caused by a change (variant) in a single gene. Variants in the APP gene, which makes the amyloid precursor protein, cause most types, including the Dutch type. Variants in the CST3 gene, which makes a protein called cystatin C, cause the Icelandic type, and variants in the ITM2B gene cause the related conditions familial British and Danish dementia. In each case the altered protein clumps together and collects in the brain and its blood vessels. The condition is inherited in an autosomal dominant pattern: one altered copy of the gene is enough to cause it, and a parent who carries the variant has a 50 percent chance of passing it to each child. Even among relatives with the same variant, the age of the first bleed and the number of bleeds vary widely. Researchers have not found that high blood pressure, high cholesterol, smoking or alcohol clearly change the timing of bleeds in the Dutch type, so a person's course is not a measure of how well they looked after themselves.
Diagnosis usually starts with a stroke, unexplained memory or thinking changes, or a known family history. Brain MRI (magnetic resonance imaging) is the key imaging test. It can show bleeds near the surface of the brain, tiny old bleeds called microbleeds, traces of past bleeding over the brain's surface and damage to the brain's white matter (its deeper connecting pathways). This pattern points toward CAA, and in Dutch-type carriers some of these changes can be seen years before any bleed causes symptoms. When CAA appears at a younger age than usual, or runs in the family, genetic testing from a blood sample can confirm which gene is involved. That matters because the type shapes the likely course. Relatives who have no symptoms can choose whether to be tested. Because a result has consequences for the person and their family, genetic counseling before and after testing helps people decide whether and when they want to know.
There is currently no treatment that removes the amyloid or stops hereditary CAA from progressing. Care aims to lower the chance of further bleeding, manage the effects of strokes and support memory, thinking and daily function, following the same approaches used for the more common sporadic form. Keeping blood pressure well controlled is a central part of care, especially after a bleed, and specialists often advise tighter control than usual. Medicines that make bleeding more likely need careful thought. Blood thinners such as anticoagulants (for example, warfarin or apixaban, Eliquis) and antiplatelet drugs (including aspirin) are restricted or used only after weighing the risks with a neurologist, and anti-inflammatory pain relievers such as ibuprofen (Advil, Motrin) and naproxen (Aleve), known as NSAIDs, are generally avoided after a CAA-related bleed. If someone also has a condition that usually calls for a blood thinner, such as atrial fibrillation, the decision is made case by case. After a stroke, hospital treatment and rehabilitation (physical, occupational and speech therapy) help people regain function. Seizures, which are common after strokes in some types, are treated with anti-seizure medicine. Medicines used for Alzheimer's symptoms, such as donepezil (Aricept), have shown only small benefits for thinking in CAA, but may be discussed in some cases. Research studies, particularly in Dutch-type families, are tracking the disease from its earliest stages to prepare for future treatment trials.
Hereditary CAA is a progressive condition, and its pace varies by type and from person to person. In the Dutch type, a first brain bleed most often happens in a person's fifties, but it can come as early as the late thirties or not until the seventies. Some people have one bleed and others have several. Each bleed can leave lasting weakness, speech or vision problems, and repeated bleeds add to the decline in thinking. Subtle changes in memory and thinking speed can appear even before the first bleed. Over time many people develop dementia and need increasing help with daily life. The condition is often fatal within about a decade after symptoms begin, typically in a person's sixties, though some live longer, and the Icelandic type tends to progress earlier. Regular follow-up with a neurologist, careful review of every new medicine for bleeding risk, rehabilitation after strokes and early planning for future care and finances help people and families keep as much control as possible. Because the condition is inherited, families often face it across generations, and genetic counseling and support groups for rare neurological diseases can help.
See a doctor, ideally a neurologist, if you have a family history of hereditary CAA or early strokes and dementia, if you notice changes in memory or thinking, or if you want to talk through genetic testing. Tell any clinician, dentist or pharmacist about the diagnosis before starting a new medicine, especially a blood thinner or a pain reliever. Call 911 right away for sudden numbness or weakness of the face, arm or leg, sudden confusion or trouble speaking, sudden trouble seeing or walking, or a sudden severe headache, because these can be signs of a brain bleed. A first episode of sudden numbness, tingling, weakness, or vision or speech trouble needs a 911 call even if it passes within minutes. CAA can also cause brief spells that keep returning in the same way. Once a doctor has assessed them, contact your care team promptly if they recur, and make sure anyone treating them knows about the CAA diagnosis, because these spells can be mistaken for mini-strokes and treated with blood thinners that raise bleeding risk. Also contact your care team promptly after a seizure or a noticeable change in thinking or behavior.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Hereditary Cerebral Amyloid Angiopathy is like, what's helped you, or ask the community a question.